Related Experiment Video

Updated: Jul 19, 2026

Generation of Null Mutants to Elucidate the Role of Bacterial Glycosyltransferases in Bacterial Motility
12:29

Generation of Null Mutants to Elucidate the Role of Bacterial Glycosyltransferases in Bacterial Motility

Published on: March 11, 2022

O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a

Joanna Kubler-Kielb1, Evgeny Vinogradov, Chiayung Chu

  • 1National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA. kielbj@mail.nih.gov

Carbohydrate Research
|November 8, 2006
PubMed

Insights

Shigella flexneri lipopolysaccharide (LPS) modifications, including O-acetylation and glucosylation, impact vaccine effectiveness. This study details O-acetylation levels and group localization in S. flexneri type 2a LPS O-specific chains.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Shigella flexneri causes significant diarrheal diseases, particularly in developing nations' infants and children.
  • Lipopolysaccharide (LPS) modifications, such as O-acetylation and glucosylation of the O-specific chain (O-SP), are crucial for LPS antigenicity and vaccine immunogenicity against shigellosis.

Purpose of the Study:

  • To investigate the degree of O-acetylation in Shigella flexneri type 2a LPS.
  • To determine the localization of O-acetyl groups within the O-SP.
  • To analyze side-chain glucose substitution in different S. flexneri type 2a LPS preparations.

Main Methods:

  • Analysis of O-acetylation levels in S. flexneri type 2a LPS.
  • Characterization of O-acetyl group and glucose substitution localization within the O-SP.
  • Comparison of LPS preparations to understand structural variations.

Main Results:

  • Detailed characterization of O-acetylation degree and localization in S. flexneri type 2a LPS O-SP.
  • Identification of side-chain glucose substitution patterns.
  • Variations in O-acetylation and glucosylation were observed across different LPS preparations.

Conclusions:

  • Understanding LPS structural modifications, specifically O-acetylation and glucosylation, is vital for developing effective polysaccharide-based vaccines against shigellosis.
  • The findings provide insights into the structural heterogeneity of S. flexneri type 2a LPS, impacting antigenicity and immunogenicity.

More Related Videos

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria12:57

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria

Published on: September 16, 2013

Epithelial Cell Infection Analyses with Shigella04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

Related Concept Videos

Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...